Jan 11 2010
Biotage (STO:BIOTA) announced on 22 January 2009 that the company had
decided to move the manufacturing of its products from its factory in
Charlottesville, Virginia, to contract manufacturers and Biotage’s
manufacturing plant in Cardiff, Wales. The transfer of this business has
now successfully been finalized. In parallel with these activities the
company has marketed the building in Charlottesville for sale. These
efforts have paid off despite the challenging climate on the US real
estate market. Sales price of the facility is USD 5,5 million, which
results in a smaller loss of approximately USD 0,1 million. Net after
transaction costs Biotage’s cash holdings increases with approximately
USD 1,3 million.
Source:
http://www.cisionwire.com